Pattern and time point of relapse in locally advanced esophagogastric adenocarcinoma after multimodal treatment: implications for a useful structured follow-up
CONCLUSIONS: The risk of relapse differs significantly between high- and low-risk patients. Only a part of relapses is associated with clinical symptoms. An individualized follow-up strategy is recommended for high- and low-risk patients considering the individual risk of relapse.PMID:37589924 | DOI:10.1007/s00432-023-05254-4
Source: Clin Med Res - Category: Research Authors: Ramona Stelmach Leonidas Apostolidis Steffen Kahle Leila Sisic Henrik Nienh üser Tim Frederik Weber Dirk J äger Georg Martin Haag Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Peritoneal Cancer | Research